Dec 12 (Reuters) - Meiji Holdings Co Ltd 2269.T
* Says co and unit Meiji Seika Pharma Co Ltd plan to acquire
49
percent stake in a succession company of The
Chemo-Sero-Therapeutic Research Institute (Kaketsuken), for 18
billion yen in total
* Says transaction date will be decided later
Source text in Japanese: https://goo.gl/LDaXyS
Further company coverage: 2269.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: Tingting.liu@thomsonreuters.com@reuters.net))